Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.

نویسندگان

  • Katherine Esposito
  • Miryam Ciotola
  • Diego Carleo
  • Bruno Schisano
  • Franco Saccomanno
  • Ferdinando Carlo Sasso
  • Domenico Cozzolino
  • Roberta Assaloni
  • Domenico Merante
  • Antonio Ceriello
  • Dario Giugliano
چکیده

OBJECTIVE The aim of this study was to assess the effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. RESEARCH DESIGN AND METHODS This was a randomized, double-blind, controlled clinical trial. One hundred subjects (54 men and 46 women) with the metabolic syndrome, as defined by the Adult Treatment Panel III, were followed for 12 months after random assignment to rosiglitazone (4 mg/day) or placebo. Primary end points were flow-mediated dilation and high-sensitivity C-reactive protein (hs-CRP) levels; secondary end points were lipid and glucose parameters, homeostasis model assessment (HOMA) of insulin sensitivity, endothelial function score, and circulating levels of interleukin (IL)-6, IL-18, and adiponectin. RESULTS Compared with 60 control subjects matched for age and sex, patients with the metabolic syndrome had decreased endothelial function, raised concentrations of inflammatory markers, and reduced insulin sensitivity. After 12 months, subjects with the metabolic syndrome receiving rosiglitazone showed improved flow-mediated vasodilation (4.2%, P < 0.001) and reduced hs-CRP levels (-0.7 mg/dl, P = 0.04), compared with the placebo group. Moreover, HOMA (-0.8, P = 0.01) and serum concentrations of IL-6 (-0.5 pg/ml, P = 0.045) and IL-18 (-31 pg/ml, P = 0.036) were significantly reduced in subjects receiving rosiglitazone, whereas adiponectin levels showed a significant increment (2.3 microg/ml, P = 0.02). High-density lipoprotein-cholesterol levels increased more and triglyceride levels decreased more in the rosiglitazone group compared with the placebo group. At 1 year of follow-up, 30 subjects receiving rosiglitazone still had features of the metabolic syndrome, compared with 45 subjects receiving placebo (P < 0.001). CONCLUSIONS Rosiglitazone might be effective in reducing the prevalence of the metabolic syndrome.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Effect of Exercise Training on Inflammatory Markers in Patient with Metabolic Syndrome: A Systematic Review and Meta-analysis

Introduction: Metabolic syndrome is associated with an increase in chronic inflammation, in which exercise training may be an effective intervention for the improvement of inflammatory markers. Accordingly, this study aimed to investigate the effect of exercise training on the inflammatory markers of interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), and C-reactive protein (CRP) in pati...

متن کامل

بررسی اثرات مصرف دانه کامل سویا و پروتیین سویای فرآوری شده بر شاخص‌های التهابی و عملکرد آندوتلیال در زنان یائسه مبتلا به هر پنج جزء سندرم متابولیک

Background: Recently on the metabolic syndrome is considered as an inflammatory disease. So factors affecting inflammation are important in this condition.Methods: This randomized cross-over clinical trial was undertaken on 42 postmenopausal women with metabolic syndrome. Participants were randomly assigned to consume a control diet (Dietary Approaches to Stop Hypertension= DASH), soy protein d...

متن کامل

Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers.

BACKGROUND Antidiabetic thiazolidinediones (TZDs), like rosiglitazone or pioglitazone, improve endothelial function in patients with type 2 diabetes or metabolic syndrome, but it is currently unknown, whether these beneficial effects of TZDs depend on their metabolic action or may be caused by direct effects on the endothelium. Therefore, the present study examined whether short-term rosiglitaz...

متن کامل

Reciprocal Association between Thyroid Function and Metabolic Syndrome: A Review Article

Introduction: Thyroid dysfunction can impair fat and glucose metabolism, blood pressure, and body weight. On the other hand, metabolic syndrome (MetS) can be associated with an increased risk of hypothyroidism. Due to the high prevalence of both disorders and the possibility of synergistic metabolic detrimental consequences in combination, this review study aimed to investigate the reciprocal a...

متن کامل

THE EFFECTS OF COMBINED EXERCISE WITH AND WITHOUT DIET ON PLASMA INFLAMMATORY BIOMARKERS AND ENDOTHELIAL DYSFUNCTION IN ELDERLY PATIENTS WITH TYPE 2 DIABETES

Background: Inflammation plays an important role in the incidence and development of metabolic disorders and exercises along with dietary restrictions for weight loss. It has beneficial effects on reducing inflammatory markers, especially in type 2 diabetes. The purpose of this study was to evaluate the effect of combined exercise (resistance-aerobic) with and without diet restriction on weight...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Diabetes care

دوره 29 5  شماره 

صفحات  -

تاریخ انتشار 2006